Big Pharma Pushing Virus Theory for Blood Pressure: Thinly-Veiled Attempt to Push "Blood Pressure Vaccine"

A new study suggesting that a common virus might play a role in hypertension has some suggesting that a vaccine might be developed against high blood pressure.

Researchers from Harvard Medical School found in laboratory studies that the herpes variant cytomegalovirus (CMV), carried in the body of 60 to 99 percent of people worldwide, increases blood vessel inflammation and causes high blood pressure in mice.

"Some cases of hypertension might be treated or prevented by antiviral therapy or a vaccine against CMV," researcher Clyde Crumpacker said.

Read more...